Related references
Note: Only part of the references are listed.Peptide therapeutics: current status and future directions
Keld Fosgerau et al.
DRUG DISCOVERY TODAY (2015)
Paclitaxel Given Once Per Week With or Without Bevacizumab in Patients With Advanced Angiosarcoma: A Randomized Phase II Trial
Isabelle L. Ray-Coquard et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Epidermal growth factor-like domain 7 promotes migration and invasion of human trophoblast cells through activation of MAPK, PI3K and NOTCH signaling pathways
M. Massimiani et al.
MOLECULAR HUMAN REPRODUCTION (2015)
Hepatocellular Carcinoma: A Phase II Randomized Controlled Double-Blind Trial of Transarterial Chemoembolization in Combination with Biweekly Intravenous Administration of Bevacizumab or a Placebo
Matthias Pinter et al.
RADIOLOGY (2015)
Epidermal Growth Factor-like Domain 7 is a Marker of the Endothelial Lineage and Active Angiogenesis
Kathryn Bambino et al.
GENESIS (2014)
Prognostic significance of epidermal growth factor-like domain 7 in pancreatic cancer
Li Zhou et al.
HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL (2014)
High expression of epidermal growth factor-like domain 7 is correlated with poor differentiation and poor prognosis in patients with epithelial ovarian cancer
Jinju Oh et al.
JOURNAL OF GYNECOLOGIC ONCOLOGY (2014)
Epidermal Growth Factor-like Domain 7 Predicts Response to First-Line Chemotherapy and Bevacizumab in Patients with Metastatic Colorectal Cancer
Torben Frostrup Hansen et al.
MOLECULAR CANCER THERAPEUTICS (2014)
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
Mark R. Gilbert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Bevacizumab for Newly Diagnosed Glioblastoma Reply
Olivier L. Chinot et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Invadopodia Are Required for Cancer Cell Extravasation and Are a Therapeutic Target for Metastasis
Hon S. Leong et al.
CELL REPORTS (2014)
Bevacizumab plus Radiotherapy-Temozolomide for Newly Diagnosed Glioblastoma
Olivier L. Chinot et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
EGFL7 ligates αvβ3 integrin to enhance vessel formation
Iva Nikolic et al.
BLOOD (2013)
Future directions for peptide therapeutics development
Allan A. Kaspar et al.
DRUG DISCOVERY TODAY (2013)
Expression of Egfl7 correlates with low-grade invasive lesions in human breast cancer
Geraldine Philippin-Lauridant et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
Anti-EGFL7 antibodies enhance stress-induced endothelial cell death and anti-VEGF efficacy
Leisa Johnson et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
P22 Viral Capsids as Nanocomposite High-Relaxivity MRI Contrast Agents
Shefah Qazi et al.
MOLECULAR PHARMACEUTICS (2013)
High-Throughput Screening of One-Bead-One-Compound Peptide Libraries Using Intact Cells
Choi-Fong Cho et al.
ACS COMBINATORIAL SCIENCE (2013)
The expression of Egfl7 in human normal tissues and epithelial tumors
Chun Fan et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2013)
Differential Uptake of Chemically Modified Cowpea Mosaic Virus Nanoparticles in Macrophage Subpopulations Present in Inflammatory and Tumor Microenvironments
Arpita Agrawal et al.
BIOMACROMOLECULES (2012)
EGFL7: a unique angiogenic signaling factor in vascular development and disease
Donna Nichol et al.
BLOOD (2012)
Discovery of Novel Integrin Ligands from Combinatorial Libraries Using a Multiplex Beads on a Bead Approach
Choi-Fong Cho et al.
NANO LETTERS (2012)
The interaction between caveolin-1 and Rho-GTPases promotes metastasis by controlling the expression of alpha5-integrin and the activation of Src, Ras and Erk
E. Arpaia et al.
ONCOGENE (2012)
Cooperative effects of aminopeptidase N (CD13) expressed by nonmalignant and cancer cells within the tumor microenvironment
Liliana Guzman-Rojas et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Multifunctional Nanoparticles: Cost Versus Benefit of Adding Targeting and Imaging Capabilities
Zhiliang Cheng et al.
SCIENCE (2012)
Egfl7 Promotes Tumor Escape from Immunity by Repressing Endothelial Cell Activation
Suzanne Delfortrie et al.
CANCER RESEARCH (2011)
Anti-Angiogenic Peptides for Cancer Therapeutics
Elena V. Rosca et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2011)
Prognostic role of epidermal growth factor-like domain 7 protein expression in laryngeal squamous cell carcinoma
J-J Li et al.
JOURNAL OF LARYNGOLOGY AND OTOLOGY (2011)
Cowpea mosaic virus nanoparticles target surface vimentin on cancer cells
Nicole F. Steinmetz et al.
NANOMEDICINE (2011)
Intravital Imaging of Human Prostate Cancer Using Viral Nanoparticles Targeted to Gastrin-Releasing Peptide Receptors
Nicole F. Steinmetz et al.
SMALL (2011)
Impaired angiogenesis and altered Notch signaling in mice overexpressing endothelial Egfl7
Donna Nichol et al.
BLOOD (2010)
Expression and clinical significance of EGFL7 in malignant glioma
Chun-hai Huang et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2010)
A fast, reproducible and low-cost method for sequence deconvolution of 'on-bead' peptides via 'on-target' maldi-TOF/TOF mass spectrometry
Giulio A. Amadei et al.
JOURNAL OF MASS SPECTROMETRY (2010)
Hydrazone Ligation Strategy to Assemble Multifunctional Viral Nanoparticles for Cell Imaging and Tumor Targeting
Florence M. Brunel et al.
NANO LETTERS (2010)
Viral nanoparticles as platforms for next-generation therapeutics and imaging devices
Nicole F. Steinmetz
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2010)
Intravital imaging of embryonic and tumor neovasculature using viral nanoparticles
Hon Sing Leong et al.
NATURE PROTOCOLS (2010)
A role for Egfl7 during endothelial organization in the embryoid body model system
Anna Durrans et al.
VASCULAR CELL (2010)
Analysis and Optimization of Copper-Catalyzed Azide-Alkyne Cycloaddition for Bioconjugation
Vu Hong et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2009)
PEGylated Viral Nanoparticles for Biomedicine: The Impact of PEG Chain Length on VNP Cell Interactions In Vitro and Ex Vivo
Nicole F. Steinmetz et al.
BIOMACROMOLECULES (2009)
Novel Role for Epidermal Growth Factor-Like Domain 7 in Metastasis of Human Hepatocellular Carcinoma
Fan Wu et al.
HEPATOLOGY (2009)
Prospective Study of Prostate Tumor Angiogenesis and Cancer-Specific Mortality in the Health Professionals Follow-Up Study
Lorelei A. Mucci et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Endothelial Targeting of Cowpea Mosaic Virus (CPMV) via Surface Vimentin
Kristopher J. Koudelka et al.
PLOS PATHOGENS (2009)
VE-statin/egfl7 regulates vascular elastogenesis by interacting with lysyl oxidases
Etienne Lelievre et al.
EMBO JOURNAL (2008)
Folic acid-mediated targeting of cowpea mosaic virus particles to tumor cells
Giuseppe Destito et al.
CHEMISTRY & BIOLOGY (2007)
Chemical introduction of reactive thiols into a viral nanoscaffold: A method that avoids virus aggregation
Nicole F. Steinmetz et al.
CHEMBIOCHEM (2007)
Therapeutic peptides: technological advances driving peptides into development
Aaron K. Sato et al.
CURRENT OPINION IN BIOTECHNOLOGY (2006)
Viral nanoparticles donning a paramagnetic coat: Conjugation of MRI contrast agents to the MS2 capsid
Elizabeth A. Anderson et al.
NANO LETTERS (2006)
Viral nanoparticles as tools for intravital vascular imaging
JD Lewis et al.
NATURE MEDICINE (2006)
EGFL7 is a chemoattractant for endothelial cells and is up-regulated in angiogenesis and arterial injury
L Campagnolo et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
The endothelial-cell-derived secreted factor Egfl7 regulates vascular tube formation
LH Parker et al.
NATURE (2004)
Egfl7, a novel epidermal growth factor-domain gene expressed in endothelial cells
MJ Fitch et al.
DEVELOPMENTAL DYNAMICS (2004)
VE-statin, an endothelial repressor of smooth muscle cell migration
F Soncin et al.
EMBO JOURNAL (2003)
Share Paper
